@dpavot:29700912 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/@dpavot/sourceid/29700912","sourcedb":"@dpavot","sourceid":"29700912","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/29700912","text":"We suggest that the combination of reduced NM23-H1, induced MACC1, and the presence of tumor budding are promising biomarkers for the prediction of recurrence and may aid the stratification of patients with stage II colon cancer for adjuvant chemotherapy.","tracks":[{"project":"PGR-FAL","denotations":[{"id":"T1","span":{"begin":60,"end":65},"obj":"346389"},{"id":"T2","span":{"begin":87,"end":92},"obj":"HP:0002664"}],"relations":[{"id":"R1","pred":"false","subj":"T1","obj":"T2"}],"attributes":[{"subj":"T1","pred":"source","obj":"PGR-FAL"},{"subj":"T2","pred":"source","obj":"PGR-FAL"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"PGR-FAL","color":"#95ec93","default":true}]}]}}